Close
Back to SEEL Stock Lookup

(SEEL) – Mergers and Acquisitions

Nov 24, 2021 08:16 AM Seelos Therapeutics (SEEL) Announces Acquisition of an Exclusive License of iX Biopharma's Proprietary Wafer-Based Delivery Platform for Sublingual Ketamine

Back to SEEL Stock Lookup